Faculty
Eugene Depasquale
Contact
International Society for Heart & Lung Transplantation: Transplant Registry Early Career Award, 2013
Effect of the UNOS policy change on rates of rejection, infection and hospital readmission following heart transplantation J Heart Lung Transplant. 2023 May 19. . View in PubMed
The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients J Heart Lung Transplant. 2023 May; 42(5):e1-e141. . View in PubMed
Effect of UNOS policy change and exception status request on outcomes in patients bridged to heart transplant with an intra-aortic balloon pump Artif Organs. 2022 May; 46(5):838-849. . View in PubMed
UNOS policy change benefits high-priority patients without harming those at low priority Am J Transplant. 2022 12; 22(12):2931-2941. . View in PubMed
Many heart transplant biopsies currently diagnosed as no rejection have mild molecular antibody-mediated rejection-related changes J Heart Lung Transplant. 2022 03; 41(3):334-344. . View in PubMed
Two is better than one: when to consider multiorgan transplant Curr Opin Organ Transplant. 2022 02 01; 27(1):86-91. . View in PubMed
Assessing the Relationship Between Molecular Rejection and Parenchymal Injury in Heart Transplant Biopsies Transplantation. 2022 11 01; 106(11):2205-2216. . View in PubMed
Acute ST-Segment Elevation Myocardial Infarction as Initial Presentation of Atypical Hemolytic-Uremic Syndrome JACC Case Rep. 2021 Apr; 3(4):561-565. . View in PubMed
Extrapulmonary manifestations of severe acute respiratory syndrome coronavirus-2 infection J Med Virol. 2021 05; 93(5):2645-2653. . View in PubMed
Relapsing Polychondritis Requiring Orthotopic Heart Transplant Despite Coronary Artery Bypass and Surgical Aortic Valve Replacement JACC Case Rep. 2020 Aug; 2(10):1527-1531. . View in PubMed
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary Heart Rhythm. 2019 11; 16(11):e373-e407. . View in PubMed
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy Heart Rhythm. 2019 11; 16(11):e301-e372. . View in PubMed
Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter study Am J Transplant. 2019 10; 19(10):2889-2899. . View in PubMed
An integrated molecular diagnostic report for heart transplant biopsies using an ensemble of diagnostic algorithms J Heart Lung Transplant. 2019 06; 38(6):636-646. . View in PubMed
Temporary Venoarterial Extracorporeal Membrane Oxygenation: Ten-Year Experience at a Cardiac Transplant Center J Intensive Care Med. 2018 May; 33(5):288-295. . View in PubMed
Understanding the Correlation Between DSA, Complement Activation, and Antibody-Mediated Rejection in Heart Transplant Recipients Transplantation. 2018 10; 102(10):e431-e438. . View in PubMed
Clinical phenomapping and outcomes after heart transplantation J Heart Lung Transplant. 2018 08; 37(8):956-966. . View in PubMed
Heart and heart-liver transplantation in adults with failing Fontan physiology Clin Transplant. 2018 08; 32(8):e13329. . View in PubMed
Predicting the Future of Cardiac Allograft Vasculopathy With Cardiac Positron Emission Tomography: Ready for Prime Time? Circ Heart Fail. 2018 06; 11(6):e005136.. View in PubMed
Prognostic utility of MELD-XI in adult congenital heart disease patients undergoing cardiac transplantation Clin Transplant. 2018 06; 32(6):e13257. . View in PubMed
Primary graft dysfunction in heart transplantation Curr Opin Organ Transplant. 2018 06; 23(3):286-294. . View in PubMed
Exploring the cardiac response to injury in heart transplant biopsies JCI Insight. 2018 10 18; 3(20). . View in PubMed
Cardiac Amyloidosis: Diagnosis and Treatment Strategies Curr Oncol Rep. 2017 Jul; 19(7):46. . View in PubMed
Survival After Heart Transplantation in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy J Card Fail. 2017 Feb; 23(2):107-112. . View in PubMed
Emerging pharmacologic and structural therapies for hypertrophic cardiomyopathy Heart Fail Rev. 2017 11; 22(6):879-888. . View in PubMed
ISHLT Transplant Registry: Youthful Investment-The Path to Progress J Heart Lung Transplant. 2017 10; 36(10):1027-1036. . View in PubMed
Heart Failure Therapies for End-Stage Chemotherapy-Induced Cardiomyopathy J Card Fail. 2016 Jun; 22(6):439-48. . View in PubMed
Familial dilated cardiomyopathy diagnosis is commonly overlooked at the time of transplant listing J Heart Lung Transplant. 2016 Apr; 35(4):474-80. . View in PubMed
Socioeconomic Disparities in Heart Transplantation: A Universal Fix? Circ Cardiovasc Qual Outcomes. 2016 11; 9(6):693-694.. View in PubMed
Team-Based Care for Outpatients with Heart Failure Heart Fail Clin. 2015 Jul; 11(3):379-405. . View in PubMed
A contemporary review of adult heart transplantation: 2012 to 2013 J Heart Lung Transplant. 2014 Aug; 33(8):775-84. . View in PubMed
Anomalous left coronary artery in hypertrophic cardiomyopathy Ann Thorac Surg. 2014 Jun; 97(6):2190-3. . View in PubMed
Management of ACCF/AHA Stage C heart failure Cardiol Clin. 2014 Feb; 32(1):73-93viii. . View in PubMed
Impact of atrial fibrillation on outcomes in heart failure Heart Fail Clin. 2013 Oct; 9(4):437-49viii. . View in PubMed
Obesity in heart failure: impact on survival and treatment modalities Expert Rev Cardiovasc Ther. 2013 Sep; 11(9):1141-53. . View in PubMed
Hypertrophic cardiomyopathy: diagnosis, risk stratification and treatment CMAJ. 2013 Feb 05; 185(2):127-34. . View in PubMed
Outcomes of adults with restrictive cardiomyopathy after heart transplantation J Heart Lung Transplant. 2012 Dec; 31(12):1269-75. . View in PubMed
Assessment of myocardial viability: review of the clinical significance Rev Cardiovasc Med. 2008; 9(4):225-31. . View in PubMed
His research interests include heart transplantation and mechanical circulatory support outcomes, as well as studies of novel heart failure and cardiomyopathy therapies. Additional interests include noninvasive rejection surveillance as well as studies of novel heart failure and cardiomyopathy therapies, including hypertrophic cardiomyopathy.
In addition, Dr. DePasquale has a strong interest in sports cardiology serves as a medical consultant for the Women’s Tennis Association and USC Athletics. He served as a medical consultant for the US Open Tennis Championships from 2003 to 2020. Additionally, he serves on a national committee for the United States Tennis Association.
